hemodynamic notes

Upload: triagestation

Post on 05-Apr-2018

227 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/2/2019 Hemodynamic Notes

    1/14

    Chapters 41 & 42Hematologic Problems

    Anemia

    Reduction in either the number of red blood cells, the amount of hemoglobin, or the hematocrit Clinical sign (not a specific disease); a manifestation of several abnormal conditions

    Average number of RBCsper cubic millimeteris 4,400,000 to 5,200,000 Each RBC contains nearly 300 million hemoglobin molecules. Each can carry 4 O2

    molecules

    When, for any reason, the hemoglobin content in the bloodstream dips below theminimum for body needs, the result is anemia, meaning (although not literally) "no

    blood." Anemia is a reduction in the number or volume of RBCs. This reduction in RBCs

    results, obviously, in a reduction in the amount of hemoglobin and, therefore, in a

    reduction in the body's oxygen-carrying capacity. Another cause of anemia could be a

    diet deficient in iron-rich foods.

    Explain Hematocrit method to include Buffy Coat Layer. Spin 3000rpm, 3 min(Hemoglobin is generally the Hematocrit divided by 3)

    Hct (%)= (0.0485 x ctHb (mmol/L) + 0.0083 x 100Cardiovascular Effects of Anemia

    Desaturation, Dyspnea, Fatigue, Hypotension, Headache, Pallor & Tachycardia.

    (Dizzy, Devious Fat Harold Had Peaches & Tomatoes.)

  • 8/2/2019 Hemodynamic Notes

    2/14

    Anatomy and Physiology Review

    Bone marrow Red blood cells (erythrocytes) White blood cells Platelets

    Accessory Organs of Blood Formation

    RBCs are terminally differentiated; that is, they can never divide. RBCs live about 120 days and then are ingested by phagocytic cells in the liver and spleen. Most of the iron in their hemoglobin is reclaimed for reuse. The remainder of the heme portion of the molecule is degraded into bile pigments and excreted

    by the liver.

    Some 3 million RBCs die and are scavenged by the liver each second. Erythropoietin (EPO), produced by the kidneys, enhances the production ofred blood cells

    (RBCs).

    Blood Cell Differentiation

  • 8/2/2019 Hemodynamic Notes

    3/14

    Review of RBC Growth Cycle

    Hemostasis/Blood Clotting

    o Platelet aggregationo Blood clotting cascadeo Intrinsic factorso Extrinsic factorso Fibrin clot formation

    Review of Platlet Growth Cycle

  • 8/2/2019 Hemodynamic Notes

    4/14

    Platelets and Blood Clotting

    Hageman (Intrinsic Pathway)(12)-- D-Dimer (Extrinsic Pathway)

    VonWillebrand (Platelet Adherence to wall) (8)

    Heterodimer (Tf)

    Alterations to Clotting Cascade

  • 8/2/2019 Hemodynamic Notes

    5/14

    Intrinsic Factors = Within the blood

    Extrinsic Factors = Outside the blood (trauma, shape & smoothness of capillary

    HemophiliaFactor IX

    Coumadin works on Factor X

    HeparinFactor Xa---> Factor V

    Anticlotting Forces

  • 8/2/2019 Hemodynamic Notes

    6/14

    Assessment Critical Foci

    Patient history Functional Patterns

    Activity Intolerance Nutrition-Metabolic Pattern

    Types of food Medications (see Table 41-3)

    Respiratory & Cardiac AssessmentDrugs

    Anticoagulantsinterfere with steps in blood clotting; limit or prevent extension of clots andprevent new clots

    Fibrinolyticsselectively degrade fibrin threads in the formed blood clot Platelet Inhibitorsprevent platelets from becoming active or activated platelets from clumping

    together

    Aspirin & PlavixPhysical Assessment

    Skin Head and neck Respiratory Cardiovascular Renal and urinarybleeding, ESRD & EPO Musculoskeletal AbdominalSpleen size, GI Bleed Central nervous systemRestlessness, Headache PsychosocialCoping, Support Nutritional status Family history and genetic risk Current health problems

    Co-Morbidities Anemia as a Sign & Symptom of a Disease

  • 8/2/2019 Hemodynamic Notes

    7/14

  • 8/2/2019 Hemodynamic Notes

    8/14

    Story of Sickle Cell Crisis at High Altitude Bolivia or anesthesia

    Sickle Cell Disease: Pathophysiology

    Normally, Sickled cells return to normal shape when low O2 condition is reversed

    Main problem of the disorder is formation of abnormal hemoglobin chains Response to local or systemic hypoxia

    RBCs sickle, decrease o2 carrying capacity & clog capillaries Sickle cell crisis

    Symptomatic after enough capillaries shut down Incidence/prevalence

    In the Unites States, around 72,000 people are symptomatic with the disease The disease occurs in about 1 in every 500 African-American births and 1 in every 1000

    to 1400 Hispanic-American births 2 million Americans, or 1 in 12 African Americans, carry the sickle cell trait.

    Sickle Cell Disease: Clinical Manifestations

    Cardiovascular changes Heart Failure SOB & Fatigue

  • 8/2/2019 Hemodynamic Notes

    9/14

    Skin changes Cool, Pallor or Cyanosis, Clubbing

    Abdominal changes Pain, firm large lumpy liver & spleen

    Renal and urinary changes Priapism Chronic Kidney Disease

    Musculoskeletal changes Pain & Ulcers

    CNS changes Fever, Infarcts, Seizures & Gait Disturbances

    Sickle Cell Disease: Assessment

    Besides assessing for the system changes common to SCD Assess Level, Location, Character and Duration of Pain Assess mental status changes O2 Saturation Levels Family and Patient Coping Mechanism and Support Systems

    SCD: Laboratory Assessment

    Hemoglobin S (HbS) < 1% for those without SCD 5% - 50% for those with SCD Trait May exceed 90% for those with SCD

    Number of RBCs with permanent sickling Hematocrit

    Low Reticulocyte count Elevatedanemia of long duration Total bilirubin

    ElevatedRelease from damaged RBCs Total white blood cells

    Elevated Imaging assessment

    Crew-cut skullSickle Cell Disease: Interventions

    Pain is the most common problem: Drug therapy48 hours of IV analgesics

  • 8/2/2019 Hemodynamic Notes

    10/14

    O2 Therapy Hypotonic IV & Oral hydration Complementary and alternative therapies (Warm & Calm) TransfusionsAvoided Fe Overload

    Goals of Treatment--- Chart 42-3 Pg. 898

    Management of vaso-occlusive crisis Management of chronic pain syndromes Management of chronic hemolytic anemia Prevention and treatment of infections Management of the complications and the various organ damage syndromes associated

    with the disease

    Prevention of stroke Detection and treatment of pulmonary hypertension

    Sickle Cell Interventions: Potential for Sepsis

    Interventions include: Prevention and early detection strategies spleen often non-functional

    Excellent Infection control practices (Handwashing) for all family & care-givers Drug therapy

    Prophylactic BID PCN Acute chest syndrome. Similar to pneumonia, this life-threatening complication is caused by

    infection or trapped sickled cells in the lung. It is characterized by chest pain, fever, and an

    abnormal chest X ray.

    Sickle Cell Disease Interventions: Potential for Multiple Organ

    Dysfunction

    Interventions include: Hydration (200ml/hr) Oxygen therapy (Monitor ABGs) Transfusion therapy (Cautiously)

    Goal to dilute the HbS levels Monitor patients FE levels closely Desfereral drug of choice

    Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Anemia

  • 8/2/2019 Hemodynamic Notes

    11/14

    Most common type of inherited hemolytic anemia G6PD necessary for the RBC to produce energy to survive normal life expectancy Effect of exposure to some drugs, benzene and other toxins Screening for this deficiency necessary before donating blood, because cells deficient in G6PD

    can be hazardous

    Hydration Osmotic diuretics Transfusions ------RBCs break

    RBC Indices

    MCV Mean Corpuscular Volume MCH Mean Corpuscular Hemoglobin MCHC Mean Corpuscular Hemoglobin Concentration RDW Relative Distribution Width

    Iron Deficiency Anemia (Microcytic)

    This common type of anemia can result from blood loss, poor intestinal absorption, orinadequate diet.

    If mildsymptoms of weakness and pallor. Evaluate adult patients for abnormal bleeding, especially from the GI tract. Treatmentincreasing oral intake of iron from food sources, oral iron supplements, or IM iron

    solutions.---Z-track

    Factors Influencing Fe Absorption

    Calcium competes with iron for absorption Substances that diminish the absorption of ferrous and ferric iron include phytates, oxalates,

    phosphates, carbonates, and tannates

    Starch and clay eating produce malabsorption of iron and iron deficiency anemia (Pica) Low gastric acid conditions whether naturally occurring (Celiac Disease), surgically or medication

    induced.

    Extensive surgical removal of the proximal small bowel or chronic diseases (eg,untreated sprue or celiac syndrome) can diminish iron absorption

    Vitamin B12 Deficiency Anemia (Macrocytic)

    Lack of vitamin B12 causes improper DNA synthesis of RBCs. Poor intake of foods containing vitamin B12, small bowel resection, tapeworm, overgrowth of

    intestinal bacteria.

    Glossitis smooth beefy tongue

  • 8/2/2019 Hemodynamic Notes

    12/14

    Fatigue & wt loss Paresthesias hands & feet, poor balance Weight loss surgery

    Pernicious Anemia

    Same as pervious slide except due to specific cause Anemia resulting from failure to absorb vitamin B12 Caused by a deficiency of intrinsic factor

    Folic Acid Deficiency Anemia

    Manifestations similar to those of vitamin B12 deficiency, but nervous system functions remainnormal

    Common causespoor nutrition, malabsorption (Crohns), alcoholism and drugs Green Leafy, Liver, Beans & Nuts

    Aplastic Anemia Deficiency of circulating RBCs because of failure of the bone marrow to produce these cells Injury to the pluripotent stem cell Pancytopenia common Treatment:

    Blood transfusions Immunosuppressive therapy Splenectomy

    Polycythemia VeraCancer of the RBCs

    Disease with a sustained increase in blood hemoglobin or hematocrit Massive production of red blood cells Excessive leukocyte production Excessive production of platelets Treatment:

    Phlebotomy Hydration Anticoagulants

    Myelodysplastic Syndromes

  • 8/2/2019 Hemodynamic Notes

    13/14

    Group of disorders caused by the formation of abnormal cells in the bone marrow Blood and platelet transfusions Erythropoietin Chelation therapy Drugs for iron overloaddeferasirox and deferoxamine mesylate

    Transfusion Therapy

    Pretransfusion responsibilities to prevent adverse transfusion reactions: Verify prescription. Test donors and recipients blood for compatibility. Examine blood bag for identification. Check expiration date. Inspect blood for discoloration, gas bubbles, or cloudiness.

    Transfusion Responsibilities

    Provide patient education. Assess vital signs. Begin transfusion slowly, and stay with patient first 15 to 30 minutes. Ask patient to report unusual sensations such as chills, shortness of breath, hives, or itching. Administer blood product per protocol. Assess for hyperkalemia.

    Blood Typing

    llele from

    Parent 1

    Allele from

    Parent 2

    Genotype of

    offspring

    Blood types of

    offspring

    A A AA A

    A B AB* AB

    A O AO A

    B A AB* AB

    B B BB B

    B O BO B

  • 8/2/2019 Hemodynamic Notes

    14/14

    O O OO O

    Human blood type is determined by co-dominant alleles This makes six different genotypes. Rh Pos or Neg makes 12 different blood types

    Types of Transfusions

    Red blood cell Platelet Plasmafresh frozen plasma Cryoprecipitate Granulocyte (white cell)

    Transfusion Reactions Febrile transfusion reactions Hemolytic transfusion reactions Allergic transfusion reactions Bacterial transfusion reactions Circulatory overload Transfusion-associated graft-versus-host disease

    Autologous Blood Transfusion

    Collection and infusion of patients own blood Eliminates compatibility problems; reduces risk for transmission of bloodborne disease Types:

    Preoperative Acute normovolemic hemodilution Intraoperative autologous transfusion Postoperative blood salvage